MediPost

Beta

KRX Filings & Disclosures 2026

Business Overview

• • Total consolidated revenue KRW 70.7B, +2.9% YoY, driven by cord blood bank and stem cell therapy sales
• • Cord blood bank sales KRW 41.5B, +5.9% YoY, surpassed 330,000 family blood storage units

Risk Factors

• • USD 10% exchange rate move → ±KRW 55.7M pre-tax impact on income, down from ±KRW 1.86B prior year
• • Financial liabilities due within 1 year KRW 33.4B, up from KRW 22.8B prior year

Management Discussion & Analysis

• • Revenue KRW 73.7B (+4.25% YoY), operating loss KRW 6.8B (-40.04%), net loss KRW 8.6B (-35.68%)
• • Cord blood bank segment revenue KRW 41.5B (+5.93%), driven by 330,000 cumulative storage cases and family cord blood multi-bag service

What are the latest MediPost DART filings in 2026?

MediPost (KRX code 078160) has filed an annual report on March 19, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did MediPost file its most recent annual report?

MediPost filed its most recent annual report on March 19, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is MediPost's KRX stock code?

MediPost's KRX stock code is 078160. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 078160 to look up all MediPost disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does MediPost file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for MediPost.

Where can I find MediPost financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from MediPost annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.